BioStar Capital
Venture capitalCharlevoix · Seed–Late Stage · 10 people tracked
Also known as BIOSTAR MANAGERS, LLC
Find your way into BioStar Capital
206 people in our graph share verified history with the BioStar Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
BioStar Capital focuses on transformational medical technology, combining clinical expertise with business and financial acumen. The firm brings together renowned healthcare clinicians, executives, and medical thought leaders alongside financial professionals to identify and back medical technology innovations. With more than two decades at the forefront of medtech investment, its strategy aims to produce meaningful outcomes for patients while generating strong returns for investors.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from the firm's website & public directories
What they invest in
from 6 of 6 portfolio companiesHealthtech ×6Biotech ×4Medical Devices ×4Deep Tech ×1Digital Health ×1Enterprise Software ×1Robotics ×1
HQs:United States×6
Investments · 6 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12022 · 13 dated
AVS develops the Pulse IVL system, a medical device for treating calcified arterial disease using a unique mechanism of action for improved deliverability in peripheral and coronary applications.
BiotechDeep TechHealthtechMedical DevicesAnn Arbor, US
Robert Chisena, Ph.D.(Co-Founder & Chief Technology Officer)Hitinder Gurm, M.D.(Chief Clinical Officer)
Co-investorsCorewell Health VenturesID Ventures
MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.
HealthtechMedical DevicesRoboticsJacksonville, US
Mark Toland(Executive Officer, Director)inAndrew Cleeland(Director)Justin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)
Co-investorsAndera PartnersDeerfield Management CompanyFidelity InvestmentsRA CapitalCorewell Health VenturesFountain Healthcare Partners
XLerateHealth supports healthcare innovation by providing resources and mentorship to startups in the sector, with a focus on regional development in the Midwest and Southeast.
BiotechDigital HealthEnterprise SoftwareHealthtechSector AgnosticLouisville, US
Bob Saunders(Chairman & Co-founder)inTed Smith(Co-founder)Jackie Willmot(CEO & Co-founder)Bobby Ferreri
Co-investorsChrysalis VenturesOCA VenturesRender Capital
Nectero Therapeutics develops therapeutic devices for vascular medicine, working with key opinion leaders in the field.
BiotechHealthtechMedical DevicesDover, US
Jack Springer(President & CEO)inBruce Roberts(Director)in
Co-investorsAphelion CapitalCorewell Health VenturesNorwest Venture Partners
Versa Vascular is developing a tricuspid valve repair device with a delivery system designed for precise, repositionable implant placement.
HealthtechMedical DevicesSanta Cruz, US
Co-investorsSanta Cruz VentureView VenturesCadence Healthcare VenturesS3 Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Portfolio news
latest coverage across their companiesVersa Vascular · santacruzworks.org · Aug 17, 2026
Nectero Medical · norwest.com · Apr 27, 2026
Frequently asked questions
- What stage does BioStar Capital invest at?
- BioStar Capital invests at the Seed, Series A, Late Stage stages.
- What is BioStar Capital's typical check size?
- BioStar Capital typically writes checks of $250K – $3M.
- What sectors does BioStar Capital focus on?
- BioStar Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is BioStar Capital located?
- BioStar Capital is headquartered in Charlevoix, US.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Sanderling Ventures is one of the oldest investment firms focused on building new biomedical companies, working in close partnership with entrepreneurs.
T. Rowe Price is a global asset management firm that actively invests across markets to pursue opportunities on behalf of its clients.